569 related articles for article (PubMed ID: 35948265)
21. [Clinical characteristics of convalescent children infected with SARS-CoV-2 Omicron variant in Tianjin].
Sun Y; Wang B; Zhang GF; Zhang X; Wang CJ; Wang DY; Li YX; Zhang J
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1054-1058. PubMed ID: 36207853
[No Abstract] [Full Text] [Related]
22. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
23. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.
Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS
J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235
[TBL] [Abstract][Full Text] [Related]
25. Monitoring algorithm of hospitalized patients in a medical center with SARS-CoV-2 (Omicron variant) infection: clinical epidemiological surveillance and immunological assessment.
Chen CS; Jian MJ; Chang CK; Chung HY; Li SY; Lin JC; Yeh KM; Yang YS; Chen CW; Hsieh SS; Tang SH; Perng CL; Chang FY; Shang HS
PeerJ; 2023; 11():e14666. PubMed ID: 36710871
[TBL] [Abstract][Full Text] [Related]
26. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and vaccination status of SARS-CoV-2 Omicron variant infected children].
Wang XL; Zhai J; Zou YX
Zhonghua Er Ke Za Zhi; 2022 Jun; 60(7):671-675. PubMed ID: 35750640
[No Abstract] [Full Text] [Related]
30. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
Deng H; Lin H; Mai Y; Liu H; Chen W
Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
[TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics of children with Omicron variant infection in Chengdu area, China].
Jiang J; Yang M; Li DY; Qiao LN; Zhang HY
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):849-854. PubMed ID: 37668034
[TBL] [Abstract][Full Text] [Related]
32. Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules.
Choi JY; Lee YJ; Ko JH; Kim SH; Kim HJ; Lee HW; Jeong H; Kim TY; Jang YG; Hong HJ; Kim MS; Lee SE; Kim YG; Chung EJ; Lim H; Jang S; Kim K; Kim SS; Ahn JY; Choi JY; Kim YC; Park YS; Peck KR; Kim B
Front Cell Infect Microbiol; 2022; 12():948014. PubMed ID: 35899050
[TBL] [Abstract][Full Text] [Related]
33. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
[TBL] [Abstract][Full Text] [Related]
34. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
35. Portable Breath-Based Volatile Organic Compound Monitoring for the Detection of COVID-19 During the Circulation of the SARS-CoV-2 Delta Variant and the Transition to the SARS-CoV-2 Omicron Variant.
Sharma R; Zang W; Tabartehfarahani A; Lam A; Huang X; Sivakumar AD; Thota C; Yang S; Dickson RP; Sjoding MW; Bisco E; Mahmood CC; Diaz KM; Sautter N; Ansari S; Ward KR; Fan X
JAMA Netw Open; 2023 Feb; 6(2):e230982. PubMed ID: 36853606
[TBL] [Abstract][Full Text] [Related]
36. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
37. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants.
de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D
Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649
[TBL] [Abstract][Full Text] [Related]
38. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
[TBL] [Abstract][Full Text] [Related]
39. Immune response and severity of Omicron BA.5 reinfection among individuals previously infected with different SARS-CoV-2 variants.
Li L; Xie Z; Li Y; Luo M; Zhang L; Feng C; Tang G; Huang H; Hou R; Xu Y; Jia S; Shi J; Fan Q; Gan Q; Yu N; Hu F; Li Y; Lan Y; Tang X; Li F; Deng X
Front Cell Infect Microbiol; 2023; 13():1277880. PubMed ID: 38188634
[TBL] [Abstract][Full Text] [Related]
40. Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection.
Zhu Z; Cai J; Tang Q; Mo YY; Deng T; Zhang X; Xu K; Wu B; Tang H; Zhang Z
BMC Pulm Med; 2023 May; 23(1):177. PubMed ID: 37217986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]